share_log

Cingulate | 4: Statement of changes in beneficial ownership of securities-Officer Brams Matthew

SEC announcement ·  Mar 7 07:05
Summary by Futu AI
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.